Form 4: Varonis Systems Director Plans Future Stock Sale Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Varonis Systems Director Fred Van Den Bosch filed a Form 4 indicating a planned sale of 3,000 shares of common stock on August 1, 2025, under a Rule 10b5-1 trading plan.

Summary

  • Director Fred Van Den Bosch of Varonis Systems Inc. (VRNS) reported a planned transaction involving the disposition of common stock.
  • The transaction entails the sale of 3,000 shares of common stock, par value $0.001 per share.
  • The sale is scheduled to occur on August 1, 2025, at a price of $55.08 per share.
  • Following this planned transaction, Van Den Bosch will beneficially own 128,666 shares directly.
  • The sale is being conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person.

Sentiment

Score: 5

Explanation: The filing reports a pre-scheduled stock sale by a director under a Rule 10b5-1 plan, which is a neutral event indicating planned liquidity or diversification rather than a direct reflection of company performance or outlook.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitive dynamics.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Insider Trading Policy AdherenceDirector Fred Van Den Bosch's planned sale of 3,000 shares is being conducted under a Rule 10b5-1 trading plan, demonstrating adherence to pre-arranged trading policies designed to avoid accusations of trading on material non-public information.08/01/2025This indicates a structured approach to insider stock transactions, which is generally viewed positively from a corporate governance perspective as it reduces the risk of insider trading allegations.

Stakeholder Impact

  • Shareholders: The planned sale of 3,000 shares by a director, while potentially interpreted negatively by some, is mitigated by its execution under a Rule 10b5-1 plan and its relatively small size compared to the company's overall market capitalization. The impact on shareholder sentiment is likely minimal.

Next Steps

  • The planned execution of the stock sale on August 1, 2025.

Key Dates

DateDescription
08/01/2025Date of planned common stock sale by Director Fred Van Den Bosch.

Recommendation

hold

The filing details a routine, pre-scheduled stock sale by a director under a Rule 10b5-1 plan. This is a common practice for liquidity or diversification and does not inherently signal a change in the company's fundamental outlook or performance. This transaction alone does not provide sufficient new information to warrant a change in investment recommendation.

Keywords

Varonis Systems, VRNS, Form 4, Insider Trading, Stock Sale, Director, 10b5-1 Plan, Equity, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.